Literature DB >> 16451774

Ethical obligations and counseling challenges in cancer genetics.

Wylie Burke1, Nancy Press.   

Abstract

Cancer genetics is creating new practice opportunities in medical genetics, oncology, and primary care. The ethical and counseling challenges of this new area of practice are not unique but sometimes take new form in the context of genetic risk. This article uses cases to explore the issues associated with shared family risk, including competing concerns of family members, duty to warn relatives of genetic risk, and testing of children and other relatives. The ethical obligations of clinicians start with the need to maintain competence in the face of rapidly evolving science. Clinicians should be able to identify patients within their practice who are candidates for genetic testing. When genetic susceptibility to cancer is identified, patients should be offered counseling and follow-up, with referral as appropriate, to ensure delivery of care consistent with current standards. When patients experience barriers to needed health care, clinicians should advocate for their needs. Clinicians must ensure the autonomy and informed decision-making of all members of cancer-prone families. Clinicians must also provide emotional support and accurate information about cancer risks and cancer risk reduction measures, including uncertainties. Teamwork among different specialties is important in addressing these challenges.

Entities:  

Mesh:

Year:  2006        PMID: 16451774     DOI: 10.6004/jnccn.2006.0018

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN: 1540-1405            Impact factor:   11.908


  3 in total

1.  Prospective Feasibility Trial of a Novel Strategy of Facilitated Cascade Genetic Testing Using Telephone Counseling.

Authors:  Melissa K Frey; Ryan M Kahn; Eloise Chapman-Davis; Francesca Tubito; Maira Pires; Paul Christos; Samantha Anderson; Semanti Mukherjee; Bailey Jordan; Stephanie V Blank; Thomas A Caputo; Ravi N Sharaf; Kenneth Offit; Kevin Holcomb; Steven Lipkin
Journal:  J Clin Oncol       Date:  2020-01-10       Impact factor: 44.544

2.  "It would be so much easier": health system-led genetic risk notification-feasibility and acceptability of cascade screening in an integrated system.

Authors:  Nora B Henrikson; Paula R Blasi; Stephanie M Fullerton; Jane Grafton; Kathleen A Leppig; Gail P Jarvik; Eric B Larson
Journal:  J Community Genet       Date:  2019-03-06

3.  The impact of an interventional counselling procedure in families with a BRCA1/2 gene mutation: efficacy and safety.

Authors:  Erica Sermijn; Liesbeth Delesie; Ellen Deschepper; Ingrid Pauwels; Maryse Bonduelle; Erik Teugels; Jacques De Grève
Journal:  Fam Cancer       Date:  2016-04       Impact factor: 2.375

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.